Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

E. Anderson · SciRah

Researcher profile · Semantic Scholar

E. Anderson

Share profile

E. Anderson — researcher profile on SciRah

h-index: 30
Works: 77
Citations: 4,452

Most-cited papers

STEROIDRECEPTORSANDPROLIFERATIONIN THE HUMANBREAST Results and Discussion Distribution of ER in Normal Human Breast Lobules
R. Clarke, A. Howell, C. Potten, E. Anderson
2006566 citations
Semantic Scholar
A putative human breast stem cell population is enriched for steroid receptor-positive cells.
R. Clarke, Katherine Spence, E. Anderson, A. Howell +2 more
2005Developmental Biology328 citations Open access
Semantic Scholar
Investigation of a new pure antiestrogen (ICI 182780) in women with primary breast cancer.
D. Defriend, A. Howell, R. Nicholson, E. Anderson +10 more
1994Cancer Research313 citations
Semantic Scholar
Estrogen receptor-positive proliferating cells in the normal and precancerous breast.
Balvinder S. Shoker, C. Jarvis, Robert B. Clarke, E. Anderson +4 more
1999American Journal of Pathology283 citations Open access
Semantic Scholar
Prospective comparison of switches in biomarker status between primary and recurrent breast cancer: the Breast Recurrence In Tissues Study (BRITS)
A. Thompson, L. Jordan, P. Quinlan, E. Anderson +3 more
2010Breast Cancer Research256 citations Open access
Semantic Scholar
Comparison of the Short-Term Biological Effects of 7α-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)-nonyl]estra-1,3,5, (10)-triene-3,17β-diol (Faslodex) versus Tamoxifen in Postmenopausal Women with Primary Breast Cancer
J. Robertson, R. Nicholson, N. Bundred, E. Anderson +8 more
2001193 citations
Semantic Scholar
The proliferation of normal human breast tissue implanted into athymic nude mice is stimulated by estrogen but not progesterone.
I. Laidlaw, R. Clarke, A. Howell, A. Owen +2 more
1995Endocrinology193 citations
Semantic Scholar
Estrogen Responsiveness and Control of Normal Human Breast Proliferation
E. Anderson, R. Clarke, A. Howell
2004Journal of mammary gland biology and neoplasia188 citations
Semantic Scholar
Steroid Receptors and Cell Cycle in Normal Mammary Epithelium
E. Anderson, R. Clarke
2004Journal of mammary gland biology and neoplasia157 citations
Semantic Scholar
Evidence of reciprocity of bcl-2 and p53 expression in human colorectal adenomas and carcinomas.
A. Watson, A. Merritt, Lorelei Jones, J. Askew +5 more
1996British Journal of Cancer143 citations Open access
Semantic Scholar
Induction of apoptosis by tamoxifen and ICI 182780 in primary breast cancer
Paul Ellis, G. Saccani-Jotti, R. Clarke, S. R. D. Johnston +9 more
1997International Journal of Cancer136 citations Open access
Semantic Scholar
Regulation of human breast epithelial stem cells
Robert B. Clarke, E. Anderson, A. Howell, C. Potten
2003Cell Proliferation135 citations Open access
Semantic Scholar
Oral contraceptive (OCP) use increases proliferation and decreases oestrogen receptor content of epithelial cells in the normal human breast
Gerard Williams, E. Anderson, A. Howell, R. Watson +3 more
1991International Journal of Cancer132 citations
Semantic Scholar
Effect of tamoxifen on Ki67 labelling index in human breast tumours and its relationship to oestrogen and progesterone receptor status.
R. Clarke, I. Laidlaw, L. Jones, A. Howell +1 more
1993British Journal of Cancer125 citations Open access
Semantic Scholar
Transforming growth factor beta 1 expression in human colorectal tumours: an independent prognostic marker in a subgroup of poor prognosis patients.
H. Robson, E. Anderson, R. James, P. Schofield
1996British Journal of Cancer110 citations Open access
Semantic Scholar
Dose-dependent change in biomarkers during neoadjuvant endocrine therapy with fulvestrant: results from NEWEST, a randomized Phase II study
I. Kuter, J. Gee, R. Hegg, C. Singer +9 more
2012Breast Cancer Research and Treatment99 citations
Semantic Scholar
Risk reducing mastectomy: outcomes in 10 European centres
D. Evans, A. Baildam, E. Anderson, A. Brain +18 more
2008Journal of Medical Genetics91 citations
Semantic Scholar
Comparison of the short-term biological effects of 7alpha-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)-nonyl]estra-1,3,5, (10)-triene-3,17beta-diol (Faslodex) versus tamoxifen in postmenopausal women with primary breast cancer.
J. Robertson, R. Nicholson, N. Bundred, E. Anderson +8 more
2001Cancer Research80 citations
Semantic Scholar
Estrogen sensitivity of normal human breast tissue in vivo and implanted into athymic nude mice: Analysis of the relationship between estrogen-induced proliferation and progesterone receptor expression
R. Clarke, A. Howell, E. Anderson
1997Breast Cancer Research and Treatment75 citations
Semantic Scholar
Prolactin receptor antagonism reduces the clonogenic capacity of breast cancer cells and potentiates doxorubicin and paclitaxel cytotoxicity
S. Howell, E. Anderson, T. Hunter, G. Farnie +1 more
2008Breast Cancer Research73 citations Open access
Semantic Scholar
A good drug made better: the fulvestrant dose-response story.
J. Robertson, J. Lindemann, S. Garnett, E. Anderson +3 more
2014Clinical Breast Cancer71 citations Open access
Semantic Scholar
Abnormal regulation of the oestrogen receptor in benign breast lesions
Balvinder S. Shoker, C. Jarvis, Robert B. Clarke, E. Anderson +4 more
2000Journal of Clinical Pathology70 citations Open access
Semantic Scholar
Cooperative action of tamoxifen and c-Src inhibition in preventing the growth of estrogen receptor–positive human breast cancer cells
M. H. Herynk, Amanda R. Beyer, Yukun Cui, H. Weiss +3 more
2006Molecular Cancer Therapeutics66 citations
Semantic Scholar
Expression of activated gelatinase in human invasive breast carcinoma
P. Brown, R. E. Bloxidge, E. Anderson, A. Howell
1993Clinical and Experimental Metastasis58 citations
Semantic Scholar
Steroid receptors in human breast cancer.
R. Clarke, E. Anderson, A. Howell
2004Trends in endocrinology and metabolism53 citations
Semantic Scholar
Fulvestrant, an estrogen receptor downregulator, reduces cell turnover index more effectively than tamoxifen.
N. Bundred, E. Anderson, R. Nicholson, M. Dowsett +2 more
2002Anticancer Research35 citations
Semantic Scholar
Effects of short-term antiestrogen treatment of primary breast cancer on estrogen receptor mRNA and protein expression and on estrogen-regulated genes
R. Mcclelland, D. L. Manning, J. Gee, E. Anderson +7 more
1996Breast Cancer Research and Treatment34 citations
Semantic Scholar
Short‐term biologic response to withdrawal of hormone replacement therapy in patients with invasive breast carcinoma
R. Prasad, G. Boland, A. Cramer, E. Anderson +2 more
2003Cancer33 citations Open access
Semantic Scholar
Development and Validation of a Gene Expression Score That Predicts Response to Fulvestrant in Breast Cancer Patients
S. Knudsen, T. Jensen, A. Hansen, W. Mazin +4 more
2014PLoS ONE32 citations Open access
Semantic Scholar
Effects of oestrogens and anti-oestrogens on normal breast tissue from women bearing BRCA1 and BRCA2 mutations
Maria Bramley, Robert B. Clarke, Anthony Howell, D. Evans +3 more
2006British Journal of Cancer31 citations Open access
Semantic Scholar
Effect of a farnesyl transferase inhibitor (R115777) on ductal carcinoma in situ of the breast in a human xenograft model and on breast and ovarian cancer cell growth in vitro and in vivo
F. Wärnberg, D. White, E. Anderson, F. Knox +3 more
2006Breast Cancer Research30 citations Open access
Semantic Scholar
Where do selective estrogen receptor modulators (SERMs) and aromatase inhibitors (AIs) now fit into breast cancer treatment algorithms?
A. Howell, S. Howell, R. Clarke, E. Anderson
2001Journal of Steroid Biochemistry and Molecular Biology28 citations
Semantic Scholar
Tamoxifen as an Agonist for Metastatic Breast Cancer
A. Howell, D. Dodwell, I. Laidlaw, H. Anderson +1 more
199027 citations
Semantic Scholar
Personalized Medicine and Imaging Differences in the Transcriptional Response to Fulvestrant and Estrogen Deprivation in ER-Positive Breast Cancer
N. Patani, A. Dunbier, H. Anderson, Z. Ghazoui +11 more
201424 citations
Semantic Scholar
Oestrogen sulphotransferases in malignant and normal human breast tissue
E. Anderson, A. Howell
1995Endocrine-Related Cancer23 citations
Semantic Scholar
Changes in the normal human breast throughout the menstrual cycle: relevance to breast carcinogenesis
E. Anderson, R. Clarke, A. Howell
1997Endocrine-Related Cancer18 citations Open access
Semantic Scholar
Oestrogens, Beatson and endocrine therapy
A. Howell, R. Clarke, E. Anderson
1997Endocrine-Related Cancer15 citations
Semantic Scholar
An evaluation of five different methods for estimating proliferation in human colorectal adenocarcinomas.
M. Wilson, E. Anderson, Jennifer Bell, J. Pearson +3 more
1994Surgical oncology14 citations
Semantic Scholar
A hybrid ligand method for androgen receptor measurement.
W. Stebbings, E. Anderson, J. Puddefoot, M. Farthing +1 more
1988Journal of Steroid Biochemistry12 citations
Semantic Scholar
Normal Breast Tissue Implanted into Athymic Nude Mice Identifies Biomarkers of the Effects of Human Pregnancy Levels of Estrogen
R. Blance, A. Sims, E. Anderson, A. Howell +1 more
2009Cancer Prevention Research10 citations
Semantic Scholar
Cellular homeostasis and the breast.
E. Anderson
2004Maturitas10 citations
Semantic Scholar
Epithelial stem cells in the mammary gland: casting light into dark corners
E. Anderson, R. Clarke
1999Breast Cancer Research8 citations Open access
Semantic Scholar
Models of new antioestrogen action in vivo: primary tumours
E. Anderson, R. Nicholson, M. Dowsett, A. Howell
19968 citations Open access
Semantic Scholar
Clues to the mechanisms of endocrine resistance from clinical studies in advanced breast cancer
A. Howell, D. Defriend, E. Anderson
1995Endocrine-Related Cancer7 citations
Semantic Scholar
Cyclical Activity and ‘Ageing’ of the Human Breast: Clues to Assessment of Risk and Strategies for Prevention
A. Howell, E. Anderson, I. Laidlaw, A. Schor +2 more
19947 citations
Semantic Scholar
Relationships between polyamine, deoxyribonucleic acid and oestrogen receptor binding site concentrations in human breast tumours.
Jimi Norman, J. Puddefoot, E. Anderson, Hannelore Braunsberg
1988European Journal of Cancer and Clinical Oncology7 citations
Semantic Scholar
HETEROGENEITY OF OESTROGEN RECEPTORS IN HUMAN BREAST TUMOURS
J. Puddefoot, E. Anderson, O. Gilmore
19866 citations
Semantic Scholar
Clinical studies with the specific ‘pure’ antioestrogen ICI 182780
A. Howell, D. Defriend, J. F. R. Robertson, R. Blamey +4 more
19965 citations Open access
Semantic Scholar
86. Pharmacokinetics, systemic and antitumour effects of the specific antioestrogen ICI 182780 in women with advanced breast cancer
D. Defriend, A. Howell, J. Robertson, R. Blamey +4 more
19955 citations Open access
Semantic Scholar
Comparison of methods for detection of fulvestrant-induced changes in breast tumor estrogen and progesterone receptor expression in a neoadjuvant trial (NEWEST).
Irene Kuter, E. Anderson, U. Emeribe, P. Finlay +2 more
2009Journal of Clinical Oncology4 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Howell×23
Invite
A. Howell — researcher profile on SciRah
R. Clarke×14
Invite
R. Clarke — researcher profile on SciRah
R. Nicholson×9
Invite
R. Nicholson — researcher profile on SciRah
M. Dowsett×8
Invite
M. Dowsett — researcher profile on SciRah

×7

Invite

C. Potten — researcher profile on SciRah

Invite

N. Bundred — researcher profile on SciRah

J. Robertson×5

Invite

J. Robertson — researcher profile on SciRah

Invite

D. Defriend — researcher profile on SciRah

Invite

R. Blamey — researcher profile on SciRah

Invite

J. Gee — researcher profile on SciRah

Invite

I. Laidlaw — researcher profile on SciRah

Invite

I. Kuter — researcher profile on SciRah